- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01547130
Yoga and Bolus Lukewarm Saline as Rapid Colonoscopy Preparation
A Single Blind, Parallel Group, Randomized Controlled Trial Comparing Solution PEG Based Colon Preparation (HalfLytely) Versus Bolus Luke Warm Saline (Shudh) and Yoga Exercise for Large Bowel Cleansing Prior to Colonoscopy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Effective large bowel cleansing prior to colonoscopy is still not achieved in all cases that undergo the procedure. The use of balanced electrolyte-polyethylene glycol (PEG) solution have improved the cleansing results and shortened the time needed for preparing the bowel. The problem with using PEG solution alone is the relatively large volume of the solution that the patients need to drink. The recommendation is to drink the solution until diarrhea fluid is clear and often 4 L or more is needed. Many patients refuse to drink the sufficient volume needed to get a clean colon due to non-palatability. Good results of bowel cleansing have also been reported with sodium phosphate solution or tablets.
The fluid volume needed to drink along with sodium phosphate is generally no problem but this regimen causes electrolyte disturbances and renal insufficiency that usually are subclinical and of no significance. Several combinations of PEG solution and laxatives have been tested before. Low-volume PEG plus Bisacodyl preparation was better tolerated but it was not as effective as standard large-volume PEG and associated with abdominal cramping.
PEG solution 2L and Bisacodyl is used for large bowel cleansing in many centers in the United States and is the standard regimen used in our colonoscopy unit. In this study the investigators compare this standard regimen taken day before colonoscopy with Bolus lukewarm saline solution taken orally with yoga exercise on the day of colonoscopy.
The result of large bowel cleansing is evaluated during the colonoscopy according to a validated scoring method. Time to the first bowel movement and total preparation time are compared. Solution palatability, patient acceptability, abdominal symptoms, discomfort and subjective grading of how hard/easy it was to complete the cleansing program are evaluated with questionnaires.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
New York
-
Middle Village, New York, United States, 11379
- Vikalp Inc.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient scheduled to undergo elective complete colonoscopy as an outpatient.
- Aged 18 or older.
- The patient gives written informed consent and can understand the information given.
- The patient can participate in the study only once.
Exclusion Criteria:
- Sodium chloride sensitivity.
- Limitation to exercise.
- Earlier resection of the large bowel or rectum.
- Known active colitis.
- Ileus or gastrointestinal obstruction.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: BLS and Yoga exercise
Patients will take a bolus intake of 8 oz.
(240mL) to 16 oz.
(480mL) of lukewarm saline water and perform yoga poses.
|
A total of 2L solution at lukewarm temperature (37.2-38.8
degrees Centigrade)consumed as bolus intake (8-16 oz in one to two minutes) alternating with yoga exercises.
|
ACTIVE_COMPARATOR: PEG (HalfLytely)
Patients followed the preparation method according to the manufacturer's standard instructions.
|
A total of 2L solution prepared as per manufacturers instructions and sipped until bowel movements are clear.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Efficacy of Large Bowel Cleansing as Assessed by the Physician Performing the Colonoscopy
Time Frame: Within 48 hours of bowel preparation
|
The primary endpoint was the "success" rate of the preparations.
Preparation efficacy was evaluated by a single, blinded endoscopist (V.A.), who performed all of the colonoscopies.
The evaluation involved the rating of six anatomical segments of the colon (rectum, sigmoid, descending colon, transverse colon, ascending colon and cecum) on the 5 point Arya Bowel Prep Scale (ABPS).
Aggregating the segmental scores resulted in overall scores.
Grade A was defined as a total overall score of 19-24, grade B as a score of 13-18, grade C as a score of 7-12, and grade D as a score of 0-6.
Grade A or B preparation was considered "successes", while grade C or D was considered "failures."
To assess the reliability of ABPS, we trained 4 gastroenterologists and 3 fellows.
|
Within 48 hours of bowel preparation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Palatability of Bowel Prep
Time Frame: Upto 24 weeks
|
Patients completed a symptom questionnaire where they rated solution palatability of their assigned prep on a 1-5 Likert scale.
A rating of more than 3 was considered as "Palatable".
|
Upto 24 weeks
|
Subjective Grading by Patients on Willingness to Repeat the Large Bowel Preparation.
Time Frame: Upto 24 weeks
|
Subjects rated the SCC as "Willingness to repeat the same prep in future"
|
Upto 24 weeks
|
Patient-reported Adverse Events.
Time Frame: Upto 24 weeks
|
Patients from both groups reported adverse events in a symptom questionnaire.
|
Upto 24 weeks
|
Total Preparation Time
Time Frame: Upto 24 weeks
|
Patients in both groups were provided with a questionnaire to record the total time required from start of assigned prep to completion of the prep.
|
Upto 24 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Vijaypal Arya, MD, Wyckoff Heights Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- WHMC-2008-35
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Neoplasms
-
Imperial College LondonCompletedColonic Diseases | Colonic Polyp | Colonic Neoplasms | Colonic Cancer | Colonic Adenocarcinoma | Colonic Adenoma | Colonic Carcinoma | Colonic Dysplasia | Colon Hyperplastic PolypUnited Kingdom
-
Hospital Universitario de MóstolesCompletedColonic Polyp | Colonic Neoplasms | Colonic Cancer
-
Institute of Gastroenterology and Advance EndoscopyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Adenoma | Colonic DiseaseArgentina
-
The University of Hong KongRecruitingColonic Polyp | Colonic Cancer | Colonic AdenomaHong Kong
-
Changi General HospitalNational University Hospital, Singapore; Singapore General Hospital; Tan Tock...CompletedColonic Polyp | Colonic Neoplasms | Colonic DysplasiaSingapore
-
University of Turin, ItalyNot yet recruitingColonic Polyp | Colonic Neoplasms | Colonic Dysplasia
-
The University of Hong KongUnknownColonic Polyps | Colonic CancersHong Kong
-
Oxford University Hospitals NHS TrustCompletedRectal Cancer | Ulcerative Colitis | Colonic Cancer | Colonic DiverticulumUnited Kingdom
-
UNC Lineberger Comprehensive Cancer CenterPfizer; AmgenActive, not recruitingColon Cancer | Colonic Cancer | Cancer of the Colon | Colon Neoplasms | Neoplasms, ColonicUnited States
-
Chinese University of Hong KongCompleted
Clinical Trials on Normal (0.9%) saline
-
Ann & Robert H Lurie Children's Hospital of ChicagoWithdrawn
-
University of HaifaWestern Galilee Hospital-NahariyaRecruiting
-
Virginia Commonwealth UniversityUnited States Department of DefenseWithdrawn
-
Vanderbilt University Medical CenterActive, not recruitingPostural Tachycardia SyndromeUnited States
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Center for Research...Active, not recruitingOrthostatic Intolerance | Postural Tachycardia Syndrome | Orthostatic TachycardiaUnited States
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Lawson Health Research InstituteCompleted
-
Tehran University of Medical SciencesTehran Heart CenterCompletedContrast Induced NephropathyIran, Islamic Republic of
-
University Hospital Inselspital, BerneCompletedCardiovascular Diseases | Valvular Heart DiseaseSwitzerland
-
Yasser S Mostafa, MDFayoum University HospitalRecruiting